Gupta N, Scharenberg A M, Burshtyn D N, Wagtmann N, Lioubin M N, Rohrschneider L R, Kinet J P, Long E O
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, Maryland 20852, USA.
J Exp Med. 1997 Aug 4;186(3):473-8. doi: 10.1084/jem.186.3.473.
Inhibition of natural killer (NK) cells by the killer cell inhibitory receptor (KIR) involves recruitment of the tyrosine phosphatase SHP-1 by KIR and is prevented by expression of a dominant negative SHP-1 mutant. Another inhibitory receptor, the low affinity Fc receptor for immunoglobulin G (IgG) (Fc gamma RIIb1), has been shown to bind SHP-1 when cocross-linked with the antigen receptor on B cells (BCR). However, coligation of Fc gamma RIIb1 with BCR and with Fc epsilon RI on mast cells leads to recruitment of the inositol 5' phosphatase SHIP and to inhibition of mast cells from SHP-1-deficient mice. In this study, we evaluated the ability of these two inhibitory receptors to block target cell lysis by NK cells, and the contribution of SHP-1 and SHIP to inhibition. Recombinant vaccinia viruses encoding chimeric receptors and dominant negative mutants of SHP-1 and SHIP were used for expression in mouse and human NK cells. When the KIR cytoplasmic tail was replaced by that of Fc gamma RIIb1, recognition of HLA class I on target cells by the extracellular domain resulted in inhibition. A dominant negative mutant of SHP-1 reverted the inhibition mediated by the KIR cytoplasmic tail but not that mediated by Fc gamma RIIb1. In contrast, a dominant negative mutant of SHIP reverted only the inhibition mediated by the Fc gamma RIIb1 tail, providing functional evidence that SHIP plays a role in the Fc gamma RIIb1-mediated negative signal. These data demonstrate that inhibition of NK cells by KIR involves primarily the tyrosine phosphatase SHP-1, whereas inhibition mediated by Fc gamma RIIb1 requires the inositol phosphatase SHIP.
杀伤细胞抑制受体(KIR)对自然杀伤(NK)细胞的抑制作用涉及KIR招募酪氨酸磷酸酶SHP-1,而显性负性SHP-1突变体的表达可阻止这种抑制作用。另一种抑制性受体,即免疫球蛋白G(IgG)的低亲和力Fc受体(FcγRIIb1),已被证明在与B细胞(BCR)上的抗原受体共交联时可结合SHP-1。然而,FcγRIIb1与BCR以及肥大细胞上的FcεRI共同连接会导致肌醇5'磷酸酶SHIP的募集,并抑制来自SHP-1缺陷小鼠的肥大细胞。在本研究中,我们评估了这两种抑制性受体阻断NK细胞对靶细胞裂解的能力,以及SHP-1和SHIP在抑制作用中的贡献。编码嵌合受体以及SHP-1和SHIP显性负性突变体的重组痘苗病毒用于在小鼠和人类NK细胞中表达。当KIR的细胞质尾巴被FcγRIIb1的细胞质尾巴取代时,细胞外结构域对靶细胞上HLA I类分子的识别会导致抑制作用。SHP-1的显性负性突变体可逆转由KIR细胞质尾巴介导的抑制作用,但不能逆转由FcγRIIb1介导的抑制作用。相反,SHIP的显性负性突变体仅能逆转由FcγRIIb1尾巴介导的抑制作用,这提供了功能性证据,表明SHIP在FcγRIIb1介导的负信号中发挥作用。这些数据表明,KIR对NK细胞的抑制作用主要涉及酪氨酸磷酸酶SHP-1,而由FcγRIIb1介导的抑制作用则需要肌醇磷酸酶SHIP。